Balance Sheet for Fortress Biotech Inc. (FBIO)

$ 1.26 r      -0.11 (-8.03%) Volume: 398.45k 4:00 PM EDT Jul 18, 2019
After Hours:  $ 1.2201   -0.0399 (-3.17%) Volume: 14.79k 7:35 PM EDT Jul 18, 2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 65,508 94,952 88,294 98,182 49,759
Restrictable Cash - - - - -
Marketable Securities 17,604 36,002 3,387 - 20,002
Accounts Receivable 7,593 8,376 3,620 - -
Loans Receivable 4,742 1,616 1,712 - -
Other Receivables 31,760 7,395 3,357 - -
Receivables 7,593 8,376 8,689 156 -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 678 171 203 - -
Inventories, Adjustments & Allowances - - - - -
Inventories 678 171 203 - -
Prepaid Expenses 6,735 5,732 9,061 1,599 702
Current Deferred Income Taxes - - - - -
Other Current Assets - 1,041 1,030 - -
Total Current Assets 111,207 183,181 109,634 99,937 70,463
Land and Improvements - - - - -
Buildings and Improvement 9,271 5,351 5,655 21 12
Machinery, Furniture and Equipment 4,919 1,695 1,926 82 82
Construction in Progress 393 1,241 - 274 -
Fixed Assets, Other - - 276 - -
Fixed Assets, Total 14,583 8,287 7,857 377 94
Gross Fixed Assets 14,583 8,287 7,857 377 94
Accumulated Depreciation (2,564) (1,171) (481) (68) (42)
Net Fixed Assets 12,019 7,116 7,376 309 52
Intangibles 1,417 883 17,408 1,250 -
Cost in Excess 55,935 18,645 18,645 - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 16,350 53,380 16,254 14,629 14,650
Total Non-Current Assets 29,786 62,769 61,097 18,673 18,862
Total Assets 140,993 245,950 170,731 118,610 89,325
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 34,216 27,634 24,295 10,438 366
Short Term Debt 19,078 4,700 1,031 - -
Notes Payable - 8,528 1,000 - -
Accrued Expenses 1,329 984 12,105 27 3,113
Accrued Liabilities 1,329 984 12,105 27 3,113
Deferred Revenues 1,495 680 - - -
Current Deferred Income Taxes - - (73) - -
Other Current Liabilities (504) 28,912 18,134 114 598
Total Current Liabilities 55,614 71,438 56,565 10,579 4,077
Long Term Debt 60,425 49,271 26,184 23,174 14,003
Deferred Income Tax 5,211 4,739 5,014 493 120
Other Non-Current Liabilities 5,210 4,738 5,014 584 722
Minority Interest 17,891 67,929 44,473 27,427 -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 83,527 121,939 75,671 51,185 14,725
Total Liabilities 139,141 193,377 132,236 61,764 18,802
Preferred Shareholder's Equity 1 1 - - -
Common Shareholder's Equity 1,851 52,572 38,495 56,846 70,523
Common Par 717 551 49 47 46
Additional Paid in Capital 397,408 364,148 283,697 246,955 212,205
Cumulative Translation Adjustments - - - - -
Retained Earnings (396,274) (312,127) (245,251) (190,156) (141,728)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 62,277 101,844 64,679 80,020 84,526
Total Equity 1,852 52,573 38,495 56,846 70,523
Total Liabilities & Shareholder's Equity 140,993 245,950 170,731 118,610 89,325
Cash Flow (144,428) (101,497) (74,046) (54,223) (20,386)
Working Capital 55,593 111,743 53,069 89,358 66,386
Free Cash Flow (108,204) (85,318) (56,318) (32,359) (16,334)
Invested Capital 62,277 101,844 64,679 80,020 84,526
Shares Outstanding - Common Class Only 57,845 50,991 48,932 47,147 46,494
Preferred Shares Outstanding 1,000 1,000 - - -
Total Ordinary Shares 57,845 50,991 48,932 47,147 46,494
Total Common Shares Outstanding 57,845 50,991 48,932 47,147 46,494
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 43,462 41,659 39,963 39,147 36,324
Diluted Weighted Shares Outstanding 43,462 41,659 39,963 39,147 36,324